Equitec Proprietary Markets’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Equitec Proprietary Markets’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-68,900	Closed	-$2.33M	–	360
2021 Q2	$2.33M	Buy	+68,900	New	+$1.76M	0.7%	28

Equitec Proprietary Markets's CNST Position: Q3 2021 in Review

Equitec Proprietary Markets sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 68,900 shares — an estimated $2.33M sold.

Equitec Proprietary Markets first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $2.33M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Equitec Proprietary Markets reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Equitec Proprietary Markets sold 68,900 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.33M.
Equitec Proprietary Markets first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Equitec Proprietary Markets's Constellation Pharmaceuticals, Inc. position peaked at $2.33M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Equitec Proprietary Markets's 13F filing for Q3 2021, filed 12 Oct 2021.